In vitro and in vivo activity of melflufen (J1)in lymphoma

BACKGROUND: Melphalan has been used in the treatment of various hematologic malignancies for almost 60 years. Today it is part of standard therapy for multiple myeloma and also as part of myeloablative regimens in association with autologous allogenic stem cell transplantation. Melflufen (melphalan...

Descripción completa

Detalles Bibliográficos
Autores principales: Delforoush, Maryam, Strese, Sara, Wickström, Malin, Larsson, Rolf, Enblad, Gunilla, Gullbo, Joachim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4820867/
https://www.ncbi.nlm.nih.gov/pubmed/27044263
http://dx.doi.org/10.1186/s12885-016-2299-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4820867/
https://www.ncbi.nlm.nih.gov/pubmed/27044263
http://dx.doi.org/10.1186/s12885-016-2299-9

Ejemplares similares